Cefpodoxime Proxetil 50 mg/5ml

Cefpodoxime Proxetil 50 mg/5ml is a oral suspension / dry syrup formulated with Cefpodoxime Proxetil 50 mg/5ml. The listed active ingredient profile is Cefpodoxime Proxetil, placing the product in the cephalosporin antibiotic category. The formulation contains a cephalosporin antibacterial that acts against susceptible bacteria by interfering with bacterial cell-wall synthesis. The liquid presentation is supplied as an oral suspension/dry-syrup product; reconstitution, shaking, storage and discard instructions must follow the approved label. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.